Quest Diagnostics Inc vs Energy Select Sector SPDR Fund — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while Energy Select Sector SPDR Fund trades at $65.09 (market cap $40.84B). The key difference: Energy Select Sector SPDR Fund is the larger of the two by market cap, and Quest Diagnostics Inc pays a 1.49% dividend while Energy Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Energy Select Sector SPDR Fund for 67 Days on average.
| DGX | XLE | |
|---|---|---|
Market Cap | $25.48B | $40.84B |
Volume | 941,866 | 50,409,268 |
Sector | Health | — |
52-Week High | $247.45 | $65.93 |
52-Week Low | $173.49 | $42.61 |
Typical Hold Time | 56 Days | 67 Days |
Enterprise Value | $31.23B | — |
Dividend Yield | 1.49% | — |
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.68% with strong year-to-date performance driven by organic growth and advanced diagnostics adoption. The company has consistently beaten earnings expectations in recent quarters with Q2 2026 EPS of $3.12 exceeding estimates. Technical indicators show a bearish bias while fundamentals remain solid with 9.19% net margin and 14.35% ROE. Recent developments include a partnership with Apple Health app and positive clinical study results.
DGX presents a mixed outlook with strong fundamental performance offset by technical weakness and regulatory headwinds. The 38% upside to consensus price target of $250 offers potential, but Medicare reimbursement cuts and bearish technical signals warrant caution. Growth in consumer testing and strategic partnerships provide catalysts, though execution risks and debt levels require monitoring.
XLE trades at $65.24, up 2.93% with a bullish technical signal from moving averages, though oscillators show caution with RSI readings above 70. The energy ETF faces mixed sentiment amid geopolitical tensions and oil price volatility, with recent news highlighting both supply risks and potential price reversals. Key support sits at $64-65 while resistance levels cluster around $66.
Outlook remains tied to oil market dynamics with Middle East tensions and Fed policy as key drivers. Investment opportunity exists for energy exposure, but risks include oil price collapse and sector rotation. The ETF's 91% oil and gas concentration amplifies commodity price sensitivity.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →